Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Weight gain

Study Reveals Weight Gain Concern Among Breast Cancer Survivors

Recent research presented at the Endocrine Society’s ENDO 2024 annual meeting reveals a concerning trend among breast cancer survivors. Nearly one in five survivors may experience weight gain exceeding 10% of their body weight post-treatment. This weight gain not only increases the risk of cancer recurrence but also raises the likelihood of cardiovascular diseases. Experts emphasize the importance of daily physical activity in helping women maintain a healthy weight following breast cancer treatment, highlighting the need for continued support and awareness in addressing post-treatment issues.

New Study Shows Tapering GLP-1 Drugs May Prevent Rebound Weight Gain

New research suggests that slowly tapering off GLP-1 drugs like Ozempic and Wegovy may help prevent rebound weight gain. A recent study revealed that patients who gradually reduced their dosage to zero were able to successfully maintain their weight. This innovative approach involved drug tapering and personalized holistic health coaching, emphasizing lifestyle modifications and behavioral changes for sustained weight loss.